Harmony Biosciences Holdings, Inc. (HRMY)
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $868.5M
- Net income
- $158.7M
- Total assets
- $1.3B
- Market cap
- $2.0B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.0B
- Shares outstanding
- 53.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 19, 2020
Harmony Biosciences Holdings, Inc. (HRMY) Stock Price
- Profitable — net income of $158.7M in FY2025.
- Trading 11% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Harmony Biosciences Holdings, Inc..
Write a review
News about Harmony Biosciences Holdings, Inc.
News & sentiment via Polygon.io
Harmony Biosciences Holdings, Inc.: frequently asked questions
Is Harmony Biosciences Holdings, Inc. an American company?
Harmony Biosciences Holdings, Inc. is a US-based company headquartered in Plymouth Meeting, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Harmony Biosciences Holdings, Inc. headquartered?
Harmony Biosciences Holdings, Inc. is headquartered in Plymouth Meeting, Pennsylvania, United States.
Is Harmony Biosciences Holdings, Inc. publicly traded?
Yes — Harmony Biosciences Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol HRMY on the NASDAQ.
What does Harmony Biosciences Holdings, Inc. do?
Harmony Biosciences Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
